KeyBanc Reiterates Overweight Rating on Recursion Pharmaceuticals (RXRX )

Go back to KeyBanc Reiterates Overweight Rating on Recursion Pharmaceuticals (RXRX )
(NASDAQ: RXRX) Delayed: 3.19 +0.01 (0.31%)
Previous Close $3.18    52 Week High
Open $3.25    52 Week Low
Day High $3.27    P/E N/A 
Day Low $3.18    EPS
Volume 4,818,176